McKechnie Duncan — SEC Form 4 filings
SEC reporting owner CIK 2062139. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-07.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2026-01-26 to 2026-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 4 filings — 11,521 shares, $5,664,790 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 2,633 shares @ $498.42 ($1,312,340) in VERTEX PHARMACEUTICALS INC / MA, filed 2026-03-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Commercial Officer | 8 | — | 5 legs · 11,521 sh · $5,664,790 | 7 |
Form 4 filings — McKechnie Duncan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 1,541 @ $519 | EDGAR |
| 2026-03-13 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 2,633 @ $498.42 | EDGAR |
| 2026-03-06 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 2,437 @ $475.30 | EDGAR |
| 2026-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 873 @ $485.11 · Sale (S): 2,500 @ $486.35 · Sale (S): 2,410 @ $489 | EDGAR |
| 2026-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 4,962 @ $0 · Tax withholding (F): 1,148 @ $483.75 | EDGAR |
| 2026-02-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,283 @ $487.76 | EDGAR |
| 2026-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 1,127 @ $468.41 | EDGAR |
| 2026-01-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 4,720 @ $0 · Grant/award (A): 2,080 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2062139 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →